tiprankstipranks
Trending News
More News >
Livero Inc. (JP:9245)
:9245
Japanese Market

Livero Inc. (9245) AI Stock Analysis

Compare
0 Followers

Top Page

JP:9245

Livero Inc.

(9245)

Select Model
Select Model
Select Model
Neutral 69 (OpenAI - 5.2)
Rating:69Neutral
Price Target:
¥2,422.00
▲(7.50% Upside)
Action:ReiteratedDate:02/18/26
The score is primarily supported by strong financial fundamentals—debt-free balance sheet, rising equity, and improving profitability with accelerating revenue growth. This is tempered by weak near-term technicals (below key moving averages with negative MACD) and a valuation that looks reasonable but not clearly cheap (P/E ~22.5, modest ~1.36% yield).
Positive Factors
Debt-free balance sheet and rising equity
Zero reported debt plus steadily rising equity materially increases financial flexibility over the medium term. This reduces interest burden, preserves capacity for organic investment, M&A or shareholder returns, and improves downside resilience against cyclical revenue shocks.
Consistent multi-year revenue growth with 2025 acceleration
Sustained, accelerating revenue growth indicates growing product adoption and market traction. A larger, expanding revenue base strengthens operating leverage potential, supports margin recovery over time, and underpins repeatable free cash generation for reinvestment.
Improved cash generation and high-quality 2025 FCF
Material improvement in operating and free cash flow, with 2025 FCF nearly matching net income, signals higher earnings quality and internal funding capacity. Reliable FCF supports sustained capex, product investment, or returns without reliance on external financing.
Negative Factors
Gross margin trending down from prior peaks
A declining gross margin trend, even from high levels, poses a structural risk to sustained operating profitability. If cost pressures or mix shifts persist, management will need pricing power or efficiency gains to preserve current operating and net margin levels long term.
Historical cash-flow volatility and working-capital swings
Meaningful variability in OCF and FCF raises the risk that timing or working-capital swings constrain investment or force external funding in stress periods. Volatile cash conversion reduces predictability of reinvestment and shareholder distributions over a multi-quarter horizon.
Uneven returns on equity and inconsistent profitability
Inconsistent ROE and episodic profit weakness point to uneven capital efficiency or cyclical exposure. This makes long-term forecasting of shareholder returns harder and suggests management must sustain improvements to convert growth into reliable, efficient returns.

Livero Inc. (9245) vs. iShares MSCI Japan ETF (EWJ)

Livero Inc. Business Overview & Revenue Model

Company DescriptionLivero Inc. provides a cloud platform in Japan. Its platform helps people to establish new living arrangements by helping them to find a place to rent, move, set up basic utilities, and easily make and manage their rental contracts. The company was incorporated in 2009 and is headquartered in Tokyo, Japan.
How the Company Makes Money

Livero Inc. Financial Statement Overview

Summary
Strong overall financial profile: steady multi-year revenue growth with accelerating 2025 growth, and a meaningful profitability rebound since 2022 (solid 2025 operating and net margins). The balance sheet is a key strength with zero debt and rising equity. Offsetting factors are margin variability (gross margin trending down from prior peak levels) and historical cash-flow volatility (notably weak 2022).
Income Statement
78
Positive
Revenue has expanded steadily from 2020–2025, with growth accelerating in 2025 (up ~11% vs. near-flat in 2024). Profitability strengthened meaningfully over the last three years: operating profit and net income rose sharply from 2022–2025, and 2025 delivered solid margins (about 17% operating margin and 12% net margin). The main caution is volatility: 2022 saw a notable drop in profitability (very low net margin), and gross margin has trended down from the exceptionally high levels seen in 2021–2023, even though it remains strong overall.
Balance Sheet
90
Very Positive
The balance sheet is conservatively positioned with zero debt reported across all periods, limiting financial risk and providing flexibility. Equity has increased consistently (from ~¥0.93B in 2020 to ~¥2.66B in 2025), alongside a growing asset base, indicating ongoing business scaling without leverage. A limitation is that returns on equity have been uneven (strong in 2020–2021, weaker in 2022–2023, then improving again in 2024), suggesting profitability has not been consistently efficient through the cycle.
Cash Flow
74
Positive
Cash generation improved materially after 2022: operating cash flow and free cash flow are strong in 2023–2025, with 2025 free cash flow (~¥953M) nearly matching net income (high quality of earnings). However, cash flow has shown meaningful volatility—2022 had very weak operating cash flow and negative free cash flow, and the cash flow support versus reported operating profit appears modest based on the provided coverage figures, implying working-capital swings or timing effects can pressure cash conversion.
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue3.93B4.36B3.59B2.90B2.56B2.38B
Gross Profit2.94B3.14B2.85B2.46B2.23B2.05B
EBITDA492.02M838.91M533.50M178.03M111.92M381.04M
Net Income308.48M531.62M338.92M103.94M50.78M239.01M
Balance Sheet
Total Assets6.99B7.49B5.83B4.40B3.46B3.05B
Cash, Cash Equivalents and Short-Term Investments2.06B2.32B1.91B1.52B1.45B1.75B
Total Debt0.000.000.000.000.000.00
Total Liabilities4.54B4.83B3.58B2.50B1.57B1.22B
Stockholders Equity2.45B2.66B2.25B1.89B1.89B1.84B
Cash Flow
Free Cash Flow0.00952.74M807.00M482.00M-57.02M273.24M
Operating Cash Flow0.00963.79M828.46M496.00M10.57M330.92M
Investing Cash Flow0.00-480.15M-456.60M-320.96M-316.95M-126.22M
Financing Cash Flow0.00-117.08M16.87M-102.74M6.41M666.90M

Livero Inc. Technical Analysis

Technical Analysis Sentiment
Positive
Last Price2253.00
Price Trends
50DMA
2268.04
Positive
100DMA
2396.13
Negative
200DMA
2117.86
Positive
Market Momentum
MACD
2.45
Negative
RSI
51.56
Neutral
STOCH
63.39
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:9245, the sentiment is Positive. The current price of 2253 is below the 20-day moving average (MA) of 2272.65, below the 50-day MA of 2268.04, and above the 200-day MA of 2117.86, indicating a bullish trend. The MACD of 2.45 indicates Negative momentum. The RSI at 51.56 is Neutral, neither overbought nor oversold. The STOCH value of 63.39 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:9245.

Livero Inc. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (60)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
79
Outperform
¥9.56B16.000.90%8.03%16.91%
69
Neutral
¥12.42B22.751.35%21.96%17.76%
65
Neutral
¥10.49B24.664.52%4.97%-24.20%
63
Neutral
¥9.16B29.9425.45%138.14%
60
Neutral
$48.67B4.58-11.27%4.14%2.83%-41.78%
58
Neutral
¥6.83B24.3242.83%26.89%
41
Neutral
¥6.82B-1.56-0.30%-304.34%
* Communication Services Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:9245
Livero Inc.
2,297.00
422.44
22.54%
JP:4176
coconala Inc.
284.00
-12.00
-4.05%
JP:4436
MINKABU THE INFONOID, Inc.
444.00
-102.00
-18.68%
JP:4644
Imagineer Co., Ltd.
1,093.00
126.25
13.06%
JP:5034
unerry, Inc.
2,451.00
671.00
37.70%
JP:5570
JENOBA CO. LTD.
672.00
-42.71
-5.98%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Feb 18, 2026